Persista Bio Inc.
Ithaca, NY
- UEI
- VSKTVBS3CBW1
- CAGE
- 9U9Y8
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 179 Graham Rd # A, Ithaca, NY 14850, USA
- Website
- persistabio.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Manufacturing clinical-grade cell capsule of O2LINE(TM) implant system for T1D - project summary manufacturing… | National Institute of Diabetes and Digestive and Kidney Diseases | $287,250 | |
| Advanced pre-clinical development of O2LINETM system for type 1 diabetes cell therapy - project summary advanced… | National Institute of Diabetes and Digestive and Kidney Diseases | $5,381,901 |
Quick answers
What is Persista Bio Inc.'s UEI?
Persista Bio Inc.'s Unique Entity ID (UEI) in SAM.gov is VSKTVBS3CBW1.
What is Persista Bio Inc.'s CAGE code?
Persista Bio Inc.'s CAGE code is 9U9Y8.
What is Persista Bio Inc.'s primary NAICS code?
Persista Bio Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Persista Bio Inc. located?
Persista Bio Inc.'s physical address in SAM.gov is 179 Graham Rd # A, Ithaca, NY 14850, USA.
Is Persista Bio Inc. registered in SAM.gov?
Yes. Persista Bio Inc.'s SAM.gov registration is active through February 17, 2027.
What is Persista Bio Inc.'s most recent federal award?
Persista Bio Inc.'s most recent federal grant award is Manufacturing clinical-grade cell capsule of O2LINE(TM) implant system for T1D - project summary manufacturing… (R43DK143903), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 11, 2025.
On GovTribe
See Persista Bio Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors